Lensar, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+31.48%
vs ±18.8% implied · ×1.67
shaded = implied · ▲▼ = realized
No other changes.
No other changes.
| Manager | Value | % base | |
|---|---|---|---|
| Brandes Investment Partners | $6.1M | 24.09% | +4.90% |
| Vanguardindex-like | $2.3M | 9.02% | +3.26% |
| Groupe la Francaise | $1.2M | 4.78% | 0.00% |
| RBF Capital | $1.1M | 4.23% | +314.39% |
| BlackRockindex-like | $1.1M | 4.14% | −70.57% |
| Manager | Value | % base | |
|---|---|---|---|
| Brandes Investment Partners | $6.1M | 24.09% | +4.90% |
| Vanguardindex-like | $2.3M | 9.02% | +3.26% |
| Groupe la Francaise | $1.2M | 4.78% | 0.00% |
| RBF Capital | $1.1M | 4.23% | +314.39% |
| BlackRockindex-like | $1.1M | 4.14% | −70.57% |
Same SIC code · 6
Same SEC industry code: Stryker Corp, 3M Co, Boston Scientific Corp and 3 more; no measured co-movers for Lensar, Inc..
Same SIC code · 6
Same SEC industry code: Stryker Corp, 3M Co, Boston Scientific Corp and 3 more; no measured co-movers for Lensar, Inc..
Annual filing, covered
10-K parsed · Mar 31 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 31 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Tall tick = annual report · Source: EDGAR
Lensar, Inc.
5.55
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
Bull1
Bear2
Expected move
Inputsspot 5.57exp Nov 20ATM strike 5ATM straddle 1.18IV 119%